1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with kw 3635 in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (kw 3635) | Trials (kw 3635) | Recent Studies (post-2010) (kw 3635) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 24 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakai, H; Suzuki, T; Takeguchi, N | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and kw 3635
| Article | Year |
|---|---|
Thromboxane A(2)-mediated Cl(-) secretion induced by platelet-activating factor in isolated rat colon.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Benzimidazoles; Benzoxepins; Carrier Proteins; Chlorides; Colon; Dinoprostone; Enzyme Inhibitors; Female; Imidazoles; In Vitro Techniques; Indoles; Intestinal Mucosa; Lipoxygenase Inhibitors; Membrane Proteins; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Thromboxane; Secretory Rate; Thromboxane A2; Thromboxane-A Synthase | 2000 |